Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Air Travel and Communicable Diseases: U.S. Preparedness, Planning and Challenges
$150.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
 
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Abstract:
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 


Available Options:
Version:
Special Focus Titles
01.The European Union and the Global Financial Crisis: A View from 2016
02.International Human Rights and Justice
03.The Dutch: Creativity in the Face of Nature
04.Freshwater Resources of the Tropical North of Australia: A Hydrobiological Perspective
05.International Perspectives on Traumatic Stress: Theory, Access, and Mental Health Services
06.Marine Benthos: Biology, Ecosystem Functions and Environmental Impact
07.Mental Health Conditions and Services in Selected African Countries: Implications for Social Work and Human Services Professions
08.Child Maltreatment: Emerging Issues in Practice, Care and Prevention
09.Creativity in Gifted Children
10.Higher Education in Hong Kong: Nurturing Students to be Caring Service Leaders
11.Moral Classroom Management in Early Childhood Education
12.The Silver Conclave: Heroes, Heroines and Villains of English Literature

Nova Science Publishers
© Copyright 2004 - 2016

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266